Remote Assessments and Genetic Determinants of Congenital and Childhood Myotonic Dystrophy
Part of paid clinical trials in Rochester, New York.
- Sponsor
- University of Rochester
- Study ID
- NCT07630389
- Status
- Recruiting
Conditions
- Childhood DM1
- Congenital DM1
- Juvenile DM1
- Myotonic Dystrophy Type 1
Eligibility Criteria
- Sex
- ALL
- Age
- 0 Years - 17 Years
- Healthy Volunteers
- Not accepted
Study Details
Myotonic dystrophy type 1 (DM1) can affect people in many different ways, even in the same family. The symptoms that children experience can be different and more severe than adults. Prior studies in children have been limited because only a small number of children could participate. In this study, we hope to learn more about these differences and what causes them. This is an observational study conducted in participants' homes and does not require travel. Instead, we will use video calls to talk with children and their parents/guardians about DM1 symptoms and how it affects the child's muscles, heart, and brain. We'll send families an iPad and the other tools they need for the study. During the video call, kids will do some simple activities to see how their body moves and functions. Parents/guardians might need to help their child with some of these activities. After the video visit, we'll get a small blood sample from the child. This can be done at a local lab or even at home. We'll then look at the child's genes in the blood sample to understand how they might be linked to their symptoms. Parents/guardians can chose to have their child's genetic test result returned to them.
Key Dates
- Start date
- Nov 13, 2023
- Status verified
- Feb 2026
- Primary completion
- Jan 1, 2030
- Completion
- Jan 1, 2030
Study Design
- Enrollment
- 100 participants (estimated)
Primary Outcome Measure
Remote assessment of cognitive function [ Time Frame: 12 months ]
Central Contacts
- Jeanne Dekdebrun585-275-0420
Locations (1)
| Facility | City | State | ZIP |
|---|---|---|---|
| University of Rochester | Rochester | New York | 14642 |
Find similar trials in Rochester, NY
Related Studies
- Myotonic Dystrophy and Facioscapulohumeral Muscular Dystrophy RegistryRecruiting · University of Rochester · Rochester, New York
- Global Open-Label Extension Study of Del-desiran for the Treatment of DM1PHASE3 · Enrolling By Invitation · Avidity Biosciences, Inc. · Los Angeles, California
- Brain Structure and Clinical Endpoints in Myotonic Dystrophy Type 2Recruiting · Wake Forest University Health Sciences · Winston-Salem, North Carolina
- Cerebrospinal Fluid Biomarkers of Myotonic DystrophyRecruiting · Massachusetts General Hospital · Boston, Massachusetts